Elevance Health reaffirms FY 2025 adjusted EPS guidance of $34.15-$34.85

Elevance Health, Inc.

Reaffirms 2025 shareholders' earnings per diluted share of $30.40-$31.10, including ~$3.75 net unfavorable items.
Adjusted shareholders' earnings guidance unchanged at $34.15-$34.85 per diluted share.
Expects 2025 year-end total medical enrollment consistent with prior guidance; Medicare Advantage members 2.2-2.25 million.
Management to reiterate these projections in investor meetings over coming weeks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.